Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985361 · ClinicalTrials.gov registry record · NA
Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus
A NA study, sponsored by ProMedica Health System.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00985361 is a NA study that has completed, run by ProMedica Health System. The registered enrollment target is 37 participants.
The verdict
NCT00985361, a NA study, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 2000 international units daily
- DIETARY_SUPPLEMENT Vitamin C 500mg daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00985361
The ClinicalTrials.gov registry entry for NCT00985361 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProMedica Health System, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 2000 international units daily is the first listed.
NCT00985361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00985361 about?
NCT00985361 is a clinical study titled "Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus". The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.
What is the current status of trial NCT00985361?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2009-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00985361?
The interventions under investigation include: Vitamin D3 2000 international units daily (DIETARY_SUPPLEMENT), Vitamin C 500mg daily (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00985361?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.